![Brett T. Staahl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brett T. Staahl active positions
Companies | Position | Start | End |
---|---|---|---|
Scribe Therapeutics, Inc.
![]() Scribe Therapeutics, Inc. BiotechnologyHealth Technology Scribe Therapeutics, Inc. engages in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Berkeley, CA. | Founder | - | - |
Corporate Officer/Principal | - | - |
Career history of Brett T. Staahl
Statistics
International
United States | 2 |
Operational
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Scribe Therapeutics, Inc.
![]() Scribe Therapeutics, Inc. BiotechnologyHealth Technology Scribe Therapeutics, Inc. engages in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Berkeley, CA. | Health Technology |
- Stock Market
- Insiders
- Brett T. Staahl
- Experience